Stay updated on Her2-BATS and Pembrolizumab in Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Her2-BATS and Pembrolizumab in Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Her2-BATS and Pembrolizumab in Metastatic Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The type of intervention has been updated from version v2.13.3 to v2.14.0.
    Difference
    0.2%
    Check dated 2025-01-12T15:39:43.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T12:15:34.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.
    Difference
    2%
    Check dated 2024-12-07T10:16:42.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The website has added new features, while several detailed data fields and options for downloading study information have been removed.
    Difference
    3%
    Check dated 2024-11-23T03:54:50.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    Several key health-related links have been removed, including those to MedlinePlus and PubMed, which may impact access to important genetic and cancer information.
    Difference
    0.4%
    Check dated 2024-11-15T22:31:10.000Z thumbnail image
  9. Check
    67 days ago
    Change Detected
    Summary
    The study status has changed from 'Recruiting' to 'Active, not recruiting', and the study has been updated with new dates and additional resources, while the previous contact information has been removed.
    Difference
    7%
    Check dated 2024-11-08T17:55:46.000Z thumbnail image

Stay in the know with updates to Her2-BATS and Pembrolizumab in Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Her2-BATS and Pembrolizumab in Metastatic Breast Cancer Clinical Trial page.